Glucose-Lowering Drugs and Fracture Risk-a Systematic Review

Z Al-Mashhadi, R Viggers, R Fuglsang-Nielsen, F de Vries, J P van den Bergh, T Harsløf, B Langdahl, S Gregersen, Jakob Starup-Linde

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)737-758
Number of pages22
JournalCurrent Osteoporosis Reports
Volume18
Issue number6
DOIs
Publication statusPublished - Dec 2020

Keywords

  • Type 2 diabetes
  • Fracture
  • Glucose-lowering drugs
  • Antidiabetics
  • Glitazones
  • Insulin
  • Systematic review
  • PEPTIDE-1 RECEPTOR AGONISTS
  • DIPEPTIDYL PEPTIDASE-4 INHIBITORS
  • TYPE-2 DIABETES-MELLITUS
  • BONE-MINERAL DENSITY
  • LONG-TERM USE
  • HIP-FRACTURES
  • IN-VIVO
  • CARDIOVASCULAR OUTCOMES
  • OSTEOPOROTIC FRACTURES
  • POSTMENOPAUSAL WOMEN

Cite this